Showing results (41-50 of 710) with videos related to
Sort By:
Pageof 71
Journal for Immunotherapy of Cancer|November 22, 2017
Biomarkers for immunotherapy in bladder cancer: a moving targetDavid H Aggen, Charles G DrakeOtology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 14, 2021
Bone Cement Internal Auditory Canal Reconstruction to Reduce CSF Leak After Vestibular Schwannoma Retrosigmoid ApproachLisa Zhang, Deepa Galaiya, Christopher M Jackson, et al.Blood|September 24, 2005
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccinesGang Zhou, Charles G Drake, Hyam I LevitskyAdvances in Immunology|May 30, 2006
Mechanisms of immune evasion by tumorsCharles G Drake, Elizabeth Jaffee, Drew M PardollInteractive Cardiovascular and Thoracic Surgery|December 1, 2009
Parabolic resection for mitral valve repairDaniel H Drake, Charles G Drake, Dino RecchiaBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 3, 2014
Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directionsAbhishek Tripathi, Charles G Drake, Lauren C HarshmanUrology|February 5, 2013
Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future researchJulie N Graff, Charles G Drake, Tomasz M BeerDiscovery Medicine|May 28, 2016
Recent advances in immunotherapy for kidney cancerMark W Ball, Mohamad E Allaf, Charles G DrakeCurrent Opinion in Immunology|January 13, 2012
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunitySuzanne L Topalian, Charles G Drake, Drew M PardollCancer Cell|April 11, 2015
Immune checkpoint blockade: a common denominator approach to cancer therapySuzanne L Topalian, Charles G Drake, Drew M PardollPageof 71